Icu Medical (ICUI) Cash from Financing Activities (2009 - 2026)
Icu Medical's (ICUI) quarterly Cash from Financing Activities came in at -$44.1 million in Q1 2026, up 21.68% YoY from -$36.3 million in Q1 2025, and down 27.95% on a QoQ basis from -$34.5 million in Q4 2025.
Icu Medical (ICUI) Cash from Financing Activities (2009 - 2026) Analysis & Trends
Icu Medical (ICUI) has 18 years of Cash from Financing Activities data on file, last reported at -$44.1 million in Q1 2026.
- Quarterly Cash from Financing Activities rose 21.68% year-over-year to -$44.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$299.3 million (down 250.93% YoY) and the FY2025 annual result came in at -$311.5 million, down 458.29% from the prior year.
- Cash from Financing Activities fell to -$44.1 million in Q1 2026, from -$34.5 million in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $1.6 billion in Q1 2022 to a low of -$195.0 million in Q2 2025.
- A 5-year average of $70.0 million and a median of -$10.4 million in 2024 frame the typical range for Cash from Financing Activities.
- Annual changes were most pronounced in 2022 — Cash from Financing Activities soared 55063.9% — and 2025, when it sank 1778.03%.
- Tracing ICUI's Cash from Financing Activities over 5 years: stood at -$10.4 million in 2022, then increased by 24.42% to -$7.8 million in 2023, then fell by 4.36% to -$8.2 million in 2024, then tumbled by 321.01% to -$34.5 million in 2025, then slipped by 27.95% to -$44.1 million in 2026.
- The last three Cash from Financing Activities figures came in at -$44.1 million (Q1 2026), -$34.5 million (Q4 2025), and -$25.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | -287.90 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | -577.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | -510.00 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | -263.16 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | -159.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | -164.80 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | -300.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | -75.80 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | -31.00 Mn |
| 10 | Icu Medical | 4.57 Bn | 4.27 Bn | 235.05 Mn | -50.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -50.24 Mn |
| Jun 30, 2026 | -50.24 Mn |
| Mar 31, 2026 | -44.12 Mn |
| Mar 31, 2026 | -44.12 Mn |
| Dec 31, 2025 | -34.49 Mn |
| Dec 31, 2025 | -34.49 Mn |
| Sep 30, 2025 | -25.69 Mn |
| Sep 30, 2025 | -25.69 Mn |
| Jun 30, 2025 | -195.02 Mn |
| Jun 30, 2025 | -195.02 Mn |
| Mar 31, 2025 | -56.34 Mn |
| Mar 31, 2025 | -56.34 Mn |
| Dec 31, 2024 | -8.19 Mn |
| Dec 31, 2024 | -8.19 Mn |
| Sep 30, 2024 | -10.38 Mn |
| Sep 30, 2024 | -10.38 Mn |
| Jun 30, 2024 | -10.38 Mn |
| Jun 30, 2024 | -10.38 Mn |
| Mar 31, 2024 | -26.85 Mn |
| Mar 31, 2024 | -26.85 Mn |